MIOS and hepatocellular carcinoma: Consistent with these findings, data mining using datasets from the Human Protein Atlas and The Cancer Genome Atlas (TCGA) showed that patients with HCC with high expression of YULINK had significantly shorter overall survival than those with low YULINK expression (P = 0.0079) (Supplementary Figure S1A).